- Knowledge center
Jérôme Majoie is the General Manager of the Foundation Fournier-Majoie, a Venture philanthropic foundation dedicated to recognize and support innovative and entrepreneurial researchers or teams, willing to develop biomolecular applications leading to improvements of diagnostics and treatments in oncology to the benefit of cancer patients. He has 14 years’ experience in the pharmaceutical industry at Lipha-Merck, Pfizer and Fournier Group in Sales Marketing, Business Development and Licensing departments. Jérôme has lived and worked in the USA, the UK, Sweden, Japan as General Manager. Since 2005, he is coaching start-up companies in the biotech industry. Jérôme holds an MBA from Hartford University (CT, USA).
Marc is a Managing Partner at QBIC Venture Partners, with a life long track record both as a pioneering biotechnologist and entrepreneur. Marc has pioneered and managed over half a dozen biotech start-up companies, including Plant Genetic Systems and Keygene. The last part of his career is dedicated to coaching young entrepreneurs towards building successful businesses as well as providing seed capital to these startups.
Marc is founder and Managing Director at PeopleWare. He is a seasoned executive, leader and strategist. Marc is an expert in operational management, detecting new business opportunities and advising start-ups, such as Cloud-Hammer and Tophima where holds a board seat. He has the unique ability to manage and navigate complex challenges.
Annie Van Broekhoven has more than 30 years’ experience in biotechnology, in particular contract R&D, process development and GMP production. She is founder and CEO till 2016 of Q-Biologicals NV, a CDMO company providing services in the field of biologicals. Prior to that she was Vice-President Biologicals at Innogenetics. Currently she is a board member of different companies and is managing director of CreaBioSupport, a consulting company dedicated to help life science companies in their growth through internal development, acquisitions and partnerships. She holds a PhD in Biochemistry from the University of Antwerp, Belgium.
Jan Hellemans is one of the founders of Biogazelle and has been CEO from 2007 to 2018. In 2014, he successfully established Biogazelle as one of the fastest growing Belgian technology companies. Jan has a master in Biotechnology, a PhD in Medical Sciences (Ghent University, Belgium) and over 15 years of experience in human genetics. He acquired extensive experience in next generation sequencing and genetic diagnostics from managing an academic core facility and introducing the corresponding wet and dry lab technology in a clinical diagnostics lab at Ghent University Hospital.
Jo Vandesompele has a Master of Science in Bio-engineering, a PhD in Medical Sciences and is professor in Functional Cancer Genomics and Applied Bioinformatics at Ghent University. His research focuses on non-coding RNA biology in cancer and development of nucleic acid quantification strategies. In 2007, he co-founded Biogazelle as a privately held Ghent University spin-off company.